These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
132 related articles for article (PubMed ID: 16361412)
1. Dendritic cells pulsed with hepatitis C virus NS3 protein induce immune responses and protection from infection with recombinant vaccinia virus expressing NS3. Yu H; Huang H; Xiang J; Babiuk LA; van Drunen Littel-van den Hurk S J Gen Virol; 2006 Jan; 87(Pt 1):1-10. PubMed ID: 16361412 [TBL] [Abstract][Full Text] [Related]
2. Immunity and protection by adoptive transfer of dendritic cells transfected with hepatitis C NS3/4A mRNA. Yu H; Babiuk LA; van Drunen Littel-van den Hurk S Vaccine; 2007 Feb; 25(10):1701-11. PubMed ID: 17240490 [TBL] [Abstract][Full Text] [Related]
3. Enhanced T cell responses against hepatitis C virus by ex vivo targeting of adenoviral particles to dendritic cells. Echeverria I; Pereboev A; Silva L; Zabaleta A; Riezu-Boj JI; Bes M; Cubero M; Borras-Cuesta F; Lasarte JJ; Esteban JI; Prieto J; Sarobe P Hepatology; 2011 Jul; 54(1):28-37. PubMed ID: 21452282 [TBL] [Abstract][Full Text] [Related]
4. Induction of antigen-specific immune responses in vivo after vaccination with dendritic cells transduced with adenoviral vectors encoding hepatitis C virus NS3. Xiang M; Eisenbach C; Lupu CM; Ernst E; Stremmel W; Encke J Viral Immunol; 2006; 19(2):210-9. PubMed ID: 16817764 [TBL] [Abstract][Full Text] [Related]
5. Enhanced and sustained CD8+ T cell responses with an adenoviral vector-based hepatitis C virus vaccine encoding NS3 linked to the MHC class II chaperone protein invariant chain. Mikkelsen M; Holst PJ; Bukh J; Thomsen AR; Christensen JP J Immunol; 2011 Feb; 186(4):2355-64. PubMed ID: 21257961 [TBL] [Abstract][Full Text] [Related]
6. Potent Anti-hepatitis C Virus (HCV) T Cell Immune Responses Induced in Mice Vaccinated with DNA-Launched RNA Replicons and Modified Vaccinia Virus Ankara-HCV. Marín MQ; Pérez P; Ljungberg K; Sorzano CÓS; Gómez CE; Liljeström P; Esteban M; García-Arriaza J J Virol; 2019 Apr; 93(7):. PubMed ID: 30674625 [TBL] [Abstract][Full Text] [Related]
7. Immunization against hepatitis C virus with a fusion protein containing the extra domain A from fibronectin and the hepatitis C virus NS3 protein. Mansilla C; Gorraiz M; Martinez M; Casares N; Arribillaga L; Rudilla F; Echeverria I; Riezu-Boj JI; Sarobe P; Borrás-Cuesta F; Prieto J; Lasarte JJ J Hepatol; 2009 Sep; 51(3):520-7. PubMed ID: 19596480 [TBL] [Abstract][Full Text] [Related]
8. Induction of primary human T cell responses against hepatitis C virus-derived antigens NS3 or core by autologous dendritic cells expressing hepatitis C virus antigens: potential for vaccine and immunotherapy. Li W; Krishnadas DK; Li J; Tyrrell DL; Agrawal B J Immunol; 2006 May; 176(10):6065-75. PubMed ID: 16670315 [TBL] [Abstract][Full Text] [Related]
9. Enhanced hepatitis C virus NS3 specific Th1 immune responses induced by co-delivery of protein antigen and CpG with cationic liposomes. Jiao X; Wang RY; Qiu Q; Alter HJ; Shih JW J Gen Virol; 2004 Jun; 85(Pt 6):1545-1553. PubMed ID: 15166438 [TBL] [Abstract][Full Text] [Related]
10. Priming with CpG-enriched plasmid and boosting with protein formulated with CpG oligodeoxynucleotides and Quil A induces strong cellular and humoral immune responses to hepatitis C virus NS3. Yu H; Babiuk LA; van Drunen Littel-van den Hurk S J Gen Virol; 2004 Jun; 85(Pt 6):1533-1543. PubMed ID: 15166437 [TBL] [Abstract][Full Text] [Related]
11. Vaccination with an adenoviral vector encoding hepatitis C virus (HCV) NS3 protein protects against infection with HCV-recombinant vaccinia virus. Arribillaga L; de Cerio AL; Sarobe P; Casares N; Gorraiz M; Vales A; Bruna-Romero O; Borrás-Cuesta F; Paranhos-Baccala G; Prieto J; Ruiz J; Lasarte JJ Vaccine; 2002 Dec; 21(3-4):202-10. PubMed ID: 12450695 [TBL] [Abstract][Full Text] [Related]
12. Strategies for loading dendritic cells with hepatitis C NS5a antigen and inducing protective immunity. Yu H; Babiuk LA; van Drunen Littel-van den Hurk S J Viral Hepat; 2008 Jun; 15(6):459-70. PubMed ID: 18221298 [TBL] [Abstract][Full Text] [Related]
13. Oral Combination Vaccine, Comprising Bifidobacterium Displaying Hepatitis C Virus Nonstructural Protein 3 and Interferon-α, Induces Strong Cellular Immunity Specific to Nonstructural Protein 3 in Mice. Kitagawa K; Omoto C; Oda T; Araki A; Saito H; Shigemura K; Katayama T; Hotta H; Shirakawa T Viral Immunol; 2017 Apr; 30(3):196-203. PubMed ID: 28112593 [TBL] [Abstract][Full Text] [Related]
14. [Enhancement of the immune response in mice with a noval HCV DNA vaccine targeting NS3 to dendritic cells]. Yin X; Wang W; Tan WJ; Deng Y; Guan J; Wen B; Chen H; Ruan L Bing Du Xue Bao; 2011 Jan; 27(1):44-9. PubMed ID: 21462505 [TBL] [Abstract][Full Text] [Related]
15. Hepatitis C virus core and nonstructural protein 3 proteins induce pro- and anti-inflammatory cytokines and inhibit dendritic cell differentiation. Dolganiuc A; Kodys K; Kopasz A; Marshall C; Do T; Romics L; Mandrekar P; Zapp M; Szabo G J Immunol; 2003 Jun; 170(11):5615-24. PubMed ID: 12759441 [TBL] [Abstract][Full Text] [Related]
16. Immunotherapy with interferon-α-induced dendritic cells for chronic HCV infection (the results of pilot clinical trial). Chernykh E; Leplina O; Oleynik E; Tikhonova M; Tyrinova T; Starostina N; Ostanin A Immunol Res; 2018 Feb; 66(1):31-43. PubMed ID: 29164490 [TBL] [Abstract][Full Text] [Related]
17. DNA immunization with hepatitis C virus (HCV) polycistronic genes or immunization by HCV DNA priming-recombinant canarypox virus boosting induces immune responses and protection from recombinant HCV-vaccinia virus infection in HLA-A2.1-transgenic mice. Pancholi P; Perkus M; Tricoche N; Liu Q; Prince AM J Virol; 2003 Jan; 77(1):382-90. PubMed ID: 12477843 [TBL] [Abstract][Full Text] [Related]
18. Removal of the C6 Vaccinia Virus Interferon-β Inhibitor in the Hepatitis C Vaccine Candidate MVA-HCV Elicited in Mice High Immunogenicity in Spite of Reduced Host Gene Expression. Marín MQ; Pérez P; Gómez CE; Sorzano CÓS; Esteban M; García-Arriaza J Viruses; 2018 Aug; 10(8):. PubMed ID: 30096846 [TBL] [Abstract][Full Text] [Related]